Published in Circulation on June 07, 2004
Ischemic Pain Control With Analgesic Methods Clinical Trial (ISCHAEMIC) | NCT02841488
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Lead exposure and cardiovascular disease--a systematic review. Environ Health Perspect (2006) 3.11
Cadmium, environmental exposure, and health outcomes. Environ Health Perspect (2010) 2.65
Cadmium exposure and incident cardiovascular disease. Epidemiology (2013) 2.55
Blood lead levels and death from all causes, cardiovascular disease, and cancer: results from the NHANES III mortality study. Environ Health Perspect (2006) 2.07
Blood cadmium and lead and chronic kidney disease in US adults: a joint analysis. Am J Epidemiol (2009) 2.06
The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT). Circ Cardiovasc Qual Outcomes (2013) 1.84
Cadmium levels in urine and mortality among U.S. adults. Environ Health Perspect (2008) 1.79
A biomonitoring study of lead, cadmium, and mercury in the blood of New York city adults. Environ Health Perspect (2007) 1.79
Cadmium exposure and hypertension in the 1999-2004 National Health and Nutrition Examination Survey (NHANES). Environ Health Perspect (2008) 1.76
Metals in urine and peripheral arterial disease. Environ Health Perspect (2005) 1.76
Mechanisms of lead-induced hypertension and cardiovascular disease. Am J Physiol Heart Circ Physiol (2008) 1.41
Cadmium exposure and all-cause and cardiovascular mortality in the U.S. general population. Environ Health Perspect (2012) 1.37
Reduction in cadmium exposure in the United States population, 1988-2008: the contribution of declining smoking rates. Environ Health Perspect (2011) 1.35
Cadmium exposure in association with history of stroke and heart failure. Environ Res (2010) 1.35
The protean toxicities of lead: new chapters in a familiar story. Int J Environ Res Public Health (2011) 1.29
Tobacco smoke exposure and levels of urinary metals in the U.S. youth and adult population: the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Int J Environ Res Public Health (2009) 1.26
Heavy metal poisoning and cardiovascular disease. J Toxicol (2011) 1.24
Waterpipe smoking: not necessarily less hazardous than cigarette smoking : Possible consequences for (cardiovascular) disease. Neth Heart J (2014) 1.20
Cadmium and peripheral arterial disease: gender differences in the 1999-2004 US National Health and Nutrition Examination Survey. Am J Epidemiol (2010) 1.18
Lab-on-a-chip sensor for detection of highly electronegative heavy metals by anodic stripping voltammetry. Biomed Microdevices (2011) 1.17
Toxic elements in tobacco and in cigarette smoke: inflammation and sensitization. Metallomics (2011) 1.16
Cigarette smoking and erectile dysfunction: focus on NO bioavailability and ROS generation. J Sex Med (2008) 1.15
Causes of death and renal tubular dysfunction in residents exposed to cadmium in the environment. Occup Environ Med (2006) 1.15
Graded associations of blood lead and urinary cadmium concentrations with oxidative-stress-related markers in the U.S. population: results from the third National Health and Nutrition Examination Survey. Environ Health Perspect (2006) 1.14
National estimates of blood lead, cadmium, and mercury levels in the Korean general adult population. Int Arch Occup Environ Health (2010) 1.14
Blood and urine cadmium, blood pressure, and hypertension: a systematic review and meta-analysis. Environ Health Perspect (2010) 1.09
The lead industry and lead water pipes "A Modest Campaign". Am J Public Health (2008) 1.07
Cadmium exposure and cardiovascular disease in the 2005 Korea National Health and Nutrition Examination Survey. Environ Res (2010) 1.07
Metal pollutants and cardiovascular disease: mechanisms and consequences of exposure. Am Heart J (2014) 1.06
Cadmium exposure and clinical cardiovascular disease: a systematic review. Curr Atheroscler Rep (2013) 1.05
Toxic metal concentrations in mainstream smoke from cigarettes available in the USA. J Anal Toxicol (2014) 1.04
Cadmium inhibits mismatch repair by blocking the ATPase activity of the MSH2-MSH6 complex. Nucleic Acids Res (2005) 1.00
HFE H63D polymorphism as a modifier of the effect of cumulative lead exposure on pulse pressure: the Normative Aging Study. Environ Health Perspect (2010) 0.99
Analysis of arterial intimal hyperplasia: review and hypothesis. Theor Biol Med Model (2007) 0.98
Environmental chemicals and DNA methylation in adults: a systematic review of the epidemiologic evidence. Clin Epigenetics (2015) 0.98
Genetic effects on toxic and essential elements in humans: arsenic, cadmium, copper, lead, mercury, selenium, and zinc in erythrocytes. Environ Health Perspect (2010) 0.96
Environmental heavy metal exposure and chronic kidney disease in the general population. J Korean Med Sci (2015) 0.96
Lead exposure is associated with decreased serum paraoxonase 1 (PON1) activity and genotypes. Environ Health Perspect (2006) 0.94
Cadmium exposure and incident peripheral arterial disease. Circ Cardiovasc Qual Outcomes (2013) 0.94
Association of blood lead (Pb) and plasma homocysteine: a cross sectional survey in Karachi, Pakistan. PLoS One (2010) 0.94
Environmental factors in cardiovascular disease. Nat Rev Cardiol (2015) 0.92
Relations between health indicators and residential proximity to coal mining in West Virginia. Am J Public Health (2008) 0.91
Associations of cadmium and lead exposure with leukocyte telomere length: findings from National Health and Nutrition Examination Survey, 1999-2002. Am J Epidemiol (2014) 0.91
An examination of the association of selected toxic metals with total and central obesity indices: NHANES 99-02. Int J Environ Res Public Health (2010) 0.90
Periodontitis as a risk factor of atherosclerosis. J Immunol Res (2014) 0.88
Evaluation of cadmium, lead, nickel and zinc status in biological samples of smokers and nonsmokers hypertensive patients. J Hum Hypertens (2010) 0.87
Assessment of carcinogenic heavy metal levels in Brazilian cigarettes. Environ Monit Assess (2010) 0.87
Cumulative smoking exposure, duration of smoking cessation, and peripheral arterial disease in middle-aged and older Korean men. BMC Public Health (2011) 0.86
Association of blood lead concentrations with mortality in older women: a prospective cohort study. Environ Health (2009) 0.84
Chronic cadmium treatment promotes oxidative stress and endothelial damage in isolated rat aorta. PLoS One (2013) 0.84
Genome-wide association study of blood lead shows multiple associations near ALAD. Hum Mol Genet (2015) 0.84
Urinary metals and heart rate variability: a cross-sectional study of urban adults in Wuhan, China. Environ Health Perspect (2014) 0.83
Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine. Curr Pharmacogenomics Person Med (2011) 0.83
Smoking, menthol cigarettes, and peripheral artery disease in U.S. adults. Nicotine Tob Res (2012) 0.82
Trend of blood lead, mercury, and cadmium levels in Korean population: data analysis of the Korea National Health and Nutrition Examination Survey. Environ Monit Assess (2015) 0.82
Heavy Metals, Cardiovascular Disease, and the Unexpected Benefits of Chelation Therapy. J Am Coll Cardiol (2016) 0.82
Effects of occupational exposure to lead on left ventricular echocardio graphic variables. ARYA Atheroscler (2012) 0.82
Cigarette smoke cadmium breakthrough from traditional filters: implications for exposure. J Anal Toxicol (2014) 0.81
Assessment of toxic elements in the samples of different cigarettes and their effect on the essential elemental status in the biological samples of Irish hypertensive consumers. J Hum Hypertens (2014) 0.81
Inhibition of DNA methylation attenuates low-dose cadmium-induced cardiac contractile and intracellular Ca(2+) anomalies. Clin Exp Pharmacol Physiol (2013) 0.81
Premature peripheral arterial disease - difficult diagnosis in very early presentation. Int J Angiol (2009) 0.81
Determination of toxic elements in different brands of cigarette by atomic absorption spectrometry using ultrasonic assisted acid digestion. Environ Monit Assess (2008) 0.80
Dietary antioxidant and anti-inflammatory intake modifies the effect of cadmium exposure on markers of systemic inflammation and oxidative stress. Environ Res (2014) 0.80
Susceptibility to particle health effects, miRNA and exosomes: rationale and study protocol of the SPHERE study. BMC Public Health (2014) 0.80
Blood lead levels of residents living around 350 abandoned metal mines in Korea. Environ Monit Assess (2011) 0.80
Cardiovascular Consequences of Childhood Secondhand Tobacco Smoke Exposure: Prevailing Evidence, Burden, and Racial and Socioeconomic Disparities: A Scientific Statement From the American Heart Association. Circulation (2016) 0.80
Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis. Ont Health Technol Assess Ser (2010) 0.79
Modification by ALAD of the association between blood lead and blood pressure in the U.S. population: results from the Third National Health and Nutrition Examination Survey. Environ Health Perspect (2010) 0.79
Cadmium exposure, intercellular adhesion molecule-1 and peripheral artery disease: a cohort and an experimental study. BMJ Open (2013) 0.79
Acute exposure to lead increases myocardial contractility independent of hypertension development. Braz J Med Biol Res (2013) 0.78
Effect of Blood Cadmium Level on Mortality in Patients Undergoing Maintenance Hemodialysis. Medicine (Baltimore) (2015) 0.78
Potentially-toxic and essential elements profile of AH1N1 patients in Mexico City. Sci Rep (2013) 0.77
The dose-response association of urinary metals with altered pulmonary function and risks of restrictive and obstructive lung diseases: a population-based study in China. BMJ Open (2015) 0.77
Epigenetic effects of cadmium in cancer: focus on melanoma. Curr Genomics (2014) 0.77
Blood erythrocyte concentrations of cadmium and lead and the risk of B-cell non-Hodgkin's lymphoma and multiple myeloma: a nested case-control study. PLoS One (2013) 0.76
Loss of Integrity: Impairment of the Blood-brain Barrier in Heavy Metal-associated Ischemic Stroke. Toxicol Res (2013) 0.76
Chelation therapy and cardiovascular disease: connecting scientific silos to benefit cardiac patients. Trends Cardiovasc Med (2014) 0.76
Chelation therapy after the trial to assess chelation therapy: results of a unique trial. Curr Opin Cardiol (2014) 0.76
Unsaturated fatty acids supplementation reduces blood lead level in rats. Biomed Res Int (2015) 0.76
The relation between occupational exposure to lead and blood pressure among employed normotensive men. J Res Med Sci (2014) 0.75
A blood pressure-associated variant of the SLC39A8 gene influences cellular cadmium accumulation and toxicity. Hum Mol Genet (2016) 0.75
Chelation therapy to treat atherosclerosis, particularly in diabetes: is it time to reconsider? Expert Rev Cardiovasc Ther (2016) 0.75
Allosteric activation of sodium-calcium exchange by picomolar concentrations of cadmium. J Physiol (2004) 0.75
Assessment of the role of paraoxonase gene polymorphism (Q192R) and paraoxonase activity in the susceptibility to atherosclerosis among lead-exposed workers. Ann Saudi Med (2011) 0.75
Association of cadmium, lead and mercury with paraoxonase 1 activity in women. PLoS One (2014) 0.75
Peripheral artery disease: epidemiology and global perspectives. Nat Rev Cardiol (2016) 0.75
The effect of chloride and sulfate ions on the adsorption of Cd2+ on clay and sandy loam Egyptian soils. ScientificWorldJournal (2014) 0.75
Association Between Blood Cadmium Levels and Mortality in Peritoneal Dialysis. Medicine (Baltimore) (2016) 0.75
Association of lead exposure with cardiovascular risk factors and diseases in Chinese adults. Environ Sci Pollut Res Int (2017) 0.75
Cadmium toxicity and treatment: An update. Caspian J Intern Med (2017) 0.75
Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98
Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med (2004) 17.79
Body-mass index and mortality in Korean men and women. N Engl J Med (2006) 7.50
Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med (2007) 6.09
A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med (2013) 5.52
Enough is enough: Stop wasting money on vitamin and mineral supplements. Ann Intern Med (2013) 5.28
Brief communication: clinical implications of short-term variability in liver function test results. Ann Intern Med (2008) 5.27
Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol (2006) 4.68
An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Arch Intern Med (2006) 4.23
Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07
Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of African American with white subjects--Atherosclerosis Risk in Communities Study. Arch Intern Med (2007) 4.05
Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010. Ann Intern Med (2014) 4.00
Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation (2004) 3.96
Chronic hyperglycemia and subclinical myocardial injury. J Am Coll Cardiol (2012) 3.91
Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA (2008) 3.83
Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ (2011) 3.69
Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS (2008) 3.66
Rapid response systems: a systematic review. Crit Care Med (2007) 3.51
Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults. Circulation (2006) 3.47
Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study. J Clin Epidemiol (2003) 3.40
T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis (2011) 3.38
Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis (2010) 3.37
Random-effects meta-analysis of inconsistent effects: a time for change. Ann Intern Med (2014) 3.30
Lead exposure and cardiovascular disease--a systematic review. Environ Health Perspect (2006) 3.11
Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. Am J Epidemiol (2005) 3.10
LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis (2007) 3.08
Meta-analysis of randomized educational and behavioral interventions in type 2 diabetes. Diabetes Educ (2003) 3.05
Method of glomerular filtration rate estimation affects prediction of mortality risk. J Am Soc Nephrol (2009) 3.05
Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med (2005) 3.00
Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care (2007) 2.92
Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am J Epidemiol (2005) 2.90
Retinal vascular caliber and the development of hypertension: a meta-analysis of individual participant data. J Hypertens (2014) 2.83
Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. Am J Kidney Dis (2010) 2.83
Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (MESA). Invest Ophthalmol Vis Sci (2006) 2.79
Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study. JAMA (2002) 2.78
Ankle-brachial index and subclinical cardiac and carotid disease: the multi-ethnic study of atherosclerosis. Am J Epidemiol (2005) 2.75
Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA (2002) 2.72
C-reactive protein is a marker for human immunodeficiency virus disease progression. Arch Intern Med (2006) 2.67
Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis (2008) 2.64
Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death. Circ Cardiovasc Imaging (2012) 2.62
Quantitative retinal venular caliber and risk of cardiovascular disease in older persons: the cardiovascular health study. Arch Intern Med (2006) 2.60
Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clin Infect Dis (2007) 2.55
Cadmium exposure and incident cardiovascular disease. Epidemiology (2013) 2.55
Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol (2013) 2.50
Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence. Environ Health Perspect (2006) 2.44
Change in estimated GFR associates with coronary heart disease and mortality. J Am Soc Nephrol (2009) 2.43
Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am J Clin Nutr (2006) 2.40
Sex-steroid hormones and electrocardiographic QT-interval duration: findings from the third National Health and Nutrition Examination Survey and the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol (2011) 2.38
The prevalence and risk factors of retinal microvascular abnormalities in older persons: The Cardiovascular Health Study. Ophthalmology (2003) 2.36
Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Eur Heart J (2011) 2.29
Diabetes in midlife and cognitive change over 20 years: a cohort study. Ann Intern Med (2014) 2.20
Retinal arteriolar diameter and risk for hypertension. Ann Intern Med (2004) 2.18
Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women. J Infect Dis (2012) 2.16
Quality of life after acute respiratory distress syndrome: a meta-analysis. Intensive Care Med (2006) 2.13
Low birthweight is associated with narrower arterioles in adults. Hypertension (2008) 2.08
Age-related macular degeneration and risk for stroke. Ann Intern Med (2006) 2.07
Blood cadmium and lead and chronic kidney disease in US adults: a joint analysis. Am J Epidemiol (2009) 2.06
Retinal microvascular abnormalities and 10-year cardiovascular mortality: a population-based case-control study. Ophthalmology (2003) 2.04
Associations of blood lead with estimated glomerular filtration rate using MDRD, CKD-EPI and serum cystatin C-based equations. Nephrol Dial Transplant (2011) 2.04
Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose. Clin Chem (2012) 2.00
Influence of serum selenium concentrations on hypertension: the Lipid Analytic Cologne cross-sectional study. J Hypertens (2012) 2.00
Systolic blood pressure, diastolic blood pressure, and pulse pressure: an evaluation of their joint effect on mortality. Ann Intern Med (2003) 1.98
Validity and reliability of self-reported diabetes in the Atherosclerosis Risk in Communities Study. Am J Epidemiol (2012) 1.98
Efficacy and safety of statin monotherapy in older adults: a meta-analysis. J Gerontol A Biol Sci Med Sci (2007) 1.97
Serum selenium and diabetes in U.S. adults. Diabetes Care (2007) 1.96
The association of hemoglobin a1c with incident heart failure among people without diabetes: the atherosclerosis risk in communities study. Diabetes (2010) 1.94
Association of diabetes, comorbidities, and A1C with functional disability in older adults: results from the National Health and Nutrition Examination Survey (NHANES), 1999-2006. Diabetes Care (2010) 1.92
Retinal microvascular abnormalities and risk of lacunar stroke: Atherosclerosis Risk in Communities Study. Stroke (2010) 1.91
Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care (2004) 1.90
Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation (2011) 1.90
Retinal vessel diameters and risk of hypertension: the Multiethnic Study of Atherosclerosis. J Hypertens (2009) 1.89
Impact of energy intake, physical activity, and population-wide weight loss on cardiovascular disease and diabetes mortality in Cuba, 1980-2005. Am J Epidemiol (2007) 1.87
Blood lead levels and mortality. Arch Intern Med (2002) 1.86
Diabetic retinopathy and risk of heart failure. J Am Coll Cardiol (2008) 1.85
Metabolic syndrome, diabetes, and incidence and progression of coronary calcium: the Multiethnic Study of Atherosclerosis study. JACC Cardiovasc Imaging (2012) 1.85
Retinal vascular caliber in persons with type 2 diabetes: the Wisconsin Epidemiological Study of Diabetic Retinopathy: XX. Ophthalmology (2006) 1.83
Aortic distensibility and retinal arteriolar narrowing: the multi-ethnic study of atherosclerosis. Hypertension (2007) 1.83
Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects. Arthritis Care Res (Hoboken) (2012) 1.83
Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults. Arch Intern Med (2008) 1.82
Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons. JAMA (2002) 1.80
Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials. Am J Clin Nutr (2012) 1.79
Cadmium levels in urine and mortality among U.S. adults. Environ Health Perspect (2008) 1.79
Orthostatic hypotension predicts mortality in middle-aged adults: the Atherosclerosis Risk In Communities (ARIC) Study. Circulation (2006) 1.79
Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study. Stroke (2005) 1.78
Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr (2011) 1.78
Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study. Stroke (2002) 1.77
Cadmium exposure and hypertension in the 1999-2004 National Health and Nutrition Examination Survey (NHANES). Environ Health Perspect (2008) 1.76
Metals in urine and peripheral arterial disease. Environ Health Perspect (2005) 1.76
Seafood intake and urine concentrations of total arsenic, dimethylarsinate and arsenobetaine in the US population. Environ Res (2010) 1.75
Hemoglobin A1c predicts healing rate in diabetic wounds. J Invest Dermatol (2011) 1.73
Retinal microvascular abnormalities and subclinical magnetic resonance imaging brain infarct: a prospective study. Brain (2010) 1.73
The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : the atherosclerosis risk in communities study. Ophthalmology (2002) 1.73
QT-interval duration and mortality rate: results from the Third National Health and Nutrition Examination Survey. Arch Intern Med (2011) 1.73